Pages that link to "Q40027533"
Jump to navigation
Jump to search
The following pages link to CNS delivery of vectored prion-specific single-chain antibodies delays disease onset (Q40027533):
Displaying 35 items.
- A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines (Q21562652) (← links)
- Engineering humoral immunity as prophylaxis or therapy (Q26800101) (← links)
- Aptamers against prion proteins and prions. (Q30860694) (← links)
- Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment (Q33809258) (← links)
- Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents (Q34036311) (← links)
- Prion protein-specific antibodies-development, modes of action and therapeutics application (Q34423386) (← links)
- Characterization of four new monoclonal antibodies against the distal N-terminal region of PrP(c). (Q35205070) (← links)
- Detection and control of prion diseases in food animals (Q36857700) (← links)
- Gene therapy for misfolding protein diseases of the central nervous system (Q36983203) (← links)
- alpha-Synuclein: a therapeutic target for Parkinson's disease? (Q37070916) (← links)
- Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions. (Q37191835) (← links)
- Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases (Q37302816) (← links)
- Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease (Q37456990) (← links)
- Development of vaccination approaches for the treatment of neurological diseases (Q37462620) (← links)
- Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases (Q37514313) (← links)
- Therapeutic interventions ameliorating prion disease (Q37557690) (← links)
- Developing intrabodies for the therapeutic suppression of neurodegenerative pathology (Q37571975) (← links)
- Immunotherapy for prion diseases: opportunities and obstacles (Q37773260) (← links)
- Antibody-based therapy in Alzheimer's disease (Q37831912) (← links)
- Immunotherapeutic approaches in prion disease: progress, challenges and potential directions. (Q38104409) (← links)
- Gene-based antibody strategies for prion diseases (Q38136658) (← links)
- Single-chain fragment variable passive immunotherapies for neurodegenerative diseases (Q38139218) (← links)
- The immunobiology of prion diseases (Q38159911) (← links)
- State of play and clinical prospects of antibody gene transfer (Q38737706) (← links)
- Recombinant Antibody Fragments for Neurodegenerative Diseases (Q38970823) (← links)
- Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice. (Q39331076) (← links)
- Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions (Q39553871) (← links)
- Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis (Q42003398) (← links)
- Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytes (Q42432218) (← links)
- PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein (Q48245277) (← links)
- Development of antibody fragments for immunotherapy of prion diseases (Q48832453) (← links)
- Therapeutic effect of peripheral administration of an anti-prion protein antibody on mice infected with prions (Q51068268) (← links)
- Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrPSc and Targeting PrPSc for Lysosomal Degradation (Q89484053) (← links)
- Immunotherapy against Prion Disease (Q90399308) (← links)
- Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9 (Q92221483) (← links)